Elekta (OTCMKTS:EKTAY) Shares Gap Up – Here’s What Happened

Elekta AB (OTCMKTS:EKTAY)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $5.0150, but opened at $5.21. Elekta shares last traded at $5.21, with a volume of 1,007 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 28th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock has a consensus rating of “Hold”.

Elekta Stock Performance

The company has a current ratio of 0.87, a quick ratio of 0.68 and a debt-to-equity ratio of 0.47. The company has a market cap of $1.94 billion, a P/E ratio of -43.83 and a beta of 1.05. The company has a 50 day moving average price of $5.26 and a 200-day moving average price of $5.64.

Elekta (OTCMKTS:EKTAY) last announced its quarterly earnings data on Thursday, August 27th. The company reported $0.07 earnings per share for the quarter. Elekta had a positive return on equity of 13.31% and a negative net margin of 2.38%.The business had revenue of $372.30 million during the quarter. On average, equities analysts expect that Elekta AB will post 0.43 earnings per share for the current fiscal year.

About Elekta

Elekta AB is a Sweden-based medical technology company focused on radiation oncology and precision treatment solutions. The company develops and supplies systems used to diagnose, plan and deliver treatments for cancer and other conditions affecting the brain and nervous system.

Its product portfolio includes linear accelerators for external-beam radiotherapy, stereotactic radiosurgery systems such as Leksell Gamma Knife, brachytherapy equipment and treatment-planning, oncology information and workflow software.